MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, Y.-C.
Right arrow Articles by Kuo, C.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, Y.-C.
Right arrow Articles by Kuo, C.-C.

Vol. 62, Issue 5, 1228-1237, November 2002

Inhibition of Na+ Current by Imipramine and Related Compounds: Different Binding Kinetics as an Inactivation Stabilizer and as an Open Channel Blocker

Ya-Chin Yang and Chung-Chin Kuo

Department of Physiology, National Taiwan University College of Medicine (Y.-C.Y., C.-C.K.); and Department of Neurology, National Taiwan University Hospital (C.-C.K.)

Use-dependent block of Na+ channels plays an important role in the action of many medications, including the anticonvulsants phenytoin, carbamazepine, and lamotrigine. These anticonvulsants all slowly yet selectively bind to a common receptor site in inactivated but not resting Na+ channels, constituting the molecular basis of the use-dependent block. However, it remains unclear what channel gating process "makes" the receptor, where the receptor is located, and how the slow drug binding rate (to the inactivated channels) is contrived. Imipramine has a diphenyl structural motif almost identical to that in carbamazepine (a dibenzazepine tricyclic compound), as well as a tertiary amine chain similar to that in many prototypical local anesthetics, and has also been reported to inhibit Na+ channels in a use-dependent fashion. We found that imipramine selectively binds to the inactivated (dissociation constant ~1.3 µM) rather than the resting Na+ channels (dissociation constant >130 µM). Moreover, imipramine rapidly blocks open Na+ channels, with a binding rate ~70-fold faster than its binding to the inactivated channels. Similarly, carbamazepine and diphenhydramine are open Na+ channel blockers with faster binding rates to the open than to the inactivated channels. These findings indicate that the anticonvulsant receptor responsible for the use-dependent block of Na+ channels is located in or near the pore (most likely in the pore mouth) and is made suitable for drug binding during channel activation. The receptor, however, continually changes its conformation in the subsequent gating process, causing the slower drug binding rates to the inactivated Na+ channels.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
N. Lenkey, R. Karoly, J. P. Kiss, B. K. Szasz, E. S. Vizi, and A. Mike
The Mechanism of Activity-Dependent Sodium Channel Inhibition by the Antidepressants Fluoxetine and Desipramine
Mol. Pharmacol., December 1, 2006; 70(6): 2052 - 2063.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
E. R. Benjamin, F. Pruthi, S. Olanrewaju, V. I. Ilyin, G. Crumley, E. Kutlina, K. J. Valenzano, and R. M. Woodward
State-Dependent Compound Inhibition of Nav1.2 Sodium Channels Using the FLIPR Vm Dye: On-Target and Off-Target Effects of Diverse Pharmacological Agents
J Biomol Screen, February 1, 2006; 11(1): 29 - 39.
[Abstract] [PDF]


Home page
Biophys. JHome page
M. D. Fuller, Z.-R. Zhang, G. Cui, and N. A. McCarty
The Block of CFTR by Scorpion Venom is State-Dependent
Biophys. J., December 1, 2005; 89(6): 3960 - 3975.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Physiol.Home page
Y.-C. Yang and C.-C. Kuo
An Inactivation Stabilizer of the Na+ Channel Acts as an Opportunistic Pore Blocker Modulated by External Na+
J. Gen. Physiol., April 25, 2005; 125(5): 465 - 481.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Physiol.Home page
R. E. Garcia-Ferreiro, D. Kerschensteiner, F. Major, F. Monje, W. Stuhmer, and L. A. Pardo
Mechanism of Block of hEag1 K+ Channels by Imipramine and Astemizole
J. Gen. Physiol., September 27, 2004; 124(4): 301 - 317.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. De Luca, S. Talon, M. De Bellis, J.-F. Desaphy, G. Lentini, F. Corbo, A. Scilimati, C. Franchini, V. Tortorella, and D. C. Camerino
Optimal Requirements for High Affinity and Use-Dependent Block of Skeletal Muscle Sodium Channel by N-Benzyl Analogs of Tocainide-Like Compounds
Mol. Pharmacol., October 1, 2003; 64(4): 932 - 945.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics